Preview Mode Links will not work in preview mode

Sep 21, 2026

Featuring perspectives from Dr David W Cescon, including the following topics:

  • First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients not eligible for immunotherapy (0:00)
  • First-line treatment of mTNBC in patients eligible for immunotherapy (12:05)
  • Adverse events (19:39)

CME information and select publications